citrate synthase

Citrate synthase is a mitochondrial matrix enzyme that catalyzes the reaction: Acetyl-CoA + Oxaloacetate + H2O → Citrate + CoA-SH. This is the first and rate-limiting step of the citric acid (Krebs/TCA) cycle, committing the two-carbon acetyl unit derived from carbohydrate, fat, or protein metabolism to oxidative energy production. The reaction is highly exergonic (large negative ΔG) and essentially irreversible, making it a key control point of the cycle. Citrate synthase activity is allosterically inhibited by ATP, NADH, succinyl-CoA, and citrate itself (feedback inhibition), reflecting the energy status of the cell—high energy charge slows the cycle. Conversely, when ADP and substrate availability are high (low energy charge), the enzyme is more active, increasing flux through the TCA cycle. Because mitochondria are the primary site of aerobic ATP production, citrate synthase activity is frequently used experimentally as a quantitative marker of mitochondrial density/mass in muscle and other tissues, particularly in exercise physiology and mitochondrial myopathy research. Clinically, deficiencies or dysfunction in TCA cycle enzymes, including citrate synthase, can be associated with mitochondrial encephalomyopathies, lactic acidosis, and impaired oxidative metabolism, though isolated citrate synthase deficiency is rare compared to other TCA cycle defects. Citrate produced can also be shuttled out of the mitochondria to the cytosol, where it serves as a precursor for fatty acid synthesis (via ATP-citrate lyase) and inhibits phosphofructokinase-1, linking the TCA cycle to broader metabolic regulation of glycolysis and lipogenesis. This makes citrate synthase not only a metabolic gatekeeper for energy production but also a metabolic sensor linking catabolic and anabolic pathways.